Colgate-Palmolive Company $CL Shares Purchased by Thurston Springer Miller Herd & Titak Inc.

Key Points

• Thurston Springer Miller Herd & Titak Inc. increased its holdings in Colgate-Palmolive Company by 17.3%, bringing its total to 34,035 shares worth approximately $3,094,000.
• Colgate-Palmolive recently reported a Q2 earnings per share of $0.92, surpassing analysts' expectations of $0.89 and achieving a revenue of $5.11 billion.
• The company declared a quarterly dividend of $0.52 per share to be paid on November 14th, with a dividend yield of 2.5% and a payout ratio of 58.43%.

Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 17.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 34,035 shares of the company's stock after acquiring an additional 5,016 shares during the period. Thurston Springer Miller Herd & Titak Inc.'s holdings in Colgate-Palmolive were worth $3,094,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of CL. Westend Capital Management LLC grew its position in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its holdings in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the last quarter. Saudi Central Bank acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $29,000. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $31,000. Finally, Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive in the 1st quarter worth about $33,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CL shares. Citigroup lowered their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Barclays lifted their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Morgan Stanley lowered their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and a consensus price target of $98.00.

Colgate-Palmolive Trading Down 0.8%

CL opened at $83.35 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The company's 50 day simple moving average is $85.95 and its two-hundred day simple moving average is $89.54. Colgate-Palmolive Company has a 1-year low of $82.29 and a 1-year high of $106.26. The firm has a market capitalization of $67.37 billion, a price-to-earnings ratio of 23.41, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business's revenue was up 1.0% on a year-over-year basis. During the same period last year, the company posted $0.91 EPS. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's payout ratio is presently 58.43%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.